Cipla Ltd.
BSE: 500087 | Sector: Health care |
NSE: CIPLA | ISIN Code: INE059A01026 |
BSE 16:01 | 01 Mar | 789.50 |
2.95 (0.38%) |
OPEN
807.70 |
HIGH
807.70 |
LOW
782.05 |
NSE 15:59 | 01 Mar | 789.80 |
2.75 (0.35%) |
OPEN
795.00 |
HIGH
800.50 |
LOW
782.00 |
OPEN | 807.70 |
PREVIOUS CLOSE | 786.55 |
VOLUME | 117960 |
52-Week high | 878.55 |
52-Week low | 356.75 |
P/E | 23.94 |
Mkt Cap.(Rs cr) | 63,669 |
Buy Price | 789.50 |
Buy Qty | 134.00 |
Sell Price | 789.55 |
Sell Qty | 3.00 |
About Cipla Ltd.
Cipla Ltd is one of the leading pharmaceutical companies in India. The company focuses on development of new formulations and has a wide range of pharmaceutical products. The product portfolio includes over 1500 products across wide range of therapeutic categories.Cipla Ltd was incorporated in the year 1935 with the name Chemical Industrial & Pharmaceutical Laboratories Ltd. Khwaja Abdul Hamied th...> More
Cipla Ltd - Key Fundamentals
Parameter | Values | ||
Market Cap | (![]() |
63,669 | |
EPS - TTM | (![]() |
[*S] | 32.98 |
P/E Ratio | (X) | [*S] | 23.94 |
Face Value | (![]() |
2 | |
Latest Dividend | (%) | 150.00 | |
Latest Dividend Date | 19 Mar 2020 | ||
Dividend Yield | (%) | 0.51 | |
Book Value / Share | (![]() |
[*S] | 233.61 |
P/B Ratio | (![]() |
[*S] | 3.38 |
News
-
Cipla plans to double share from consumer health business in 5 years
-
Nifty Pharma index surges 4%; Sun Pharma, Cipla hit 52-week highs
-
Cipla's net profit zooms 113% in December quarter; revenue up 18%
-
Bright outlook: Sun Pharma to Cipla, drug firms set for Q3 health boost
-
Trading calls by Ajit Mishra of Religare Broking: Buy Cipla, Eicher Motors
Announcement
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Cipla Limited - Analysts/Institutional Investor Meet/Con. Call Updates
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Cipla Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Cipla Ltd - Financial Results
Particulars (![]() |
Dec 2020 | Dec 2019 | % Chg |
Net Sales | 5168.69 | 4371 | 18.25 |
Other Income | 86.94 | 72.13 | 20.53 |
Total Income | 5255.63 | 4443.13 | 18.29 |
Total Expenses | 3937.81 | 3612.67 | 9 |
Operating Profit | 1317.82 | 830.46 | 58.69 |
Net Profit | 752.51 | 353.58 | 112.83 |
Equity Capital | 161.29 | 161.25 | - |
Cipla Ltd - Peer Group
Company | Price(![]() |
Chg (%) | Mkt Cap (![]() |
Sun Pharma.Inds. | 604.30 | 1.51 | 144989.69 |
Divi's Lab. | 3462.80 | 2.81 | 91920.03 |
Dr Reddy's Labs | 4453.30 | 0.65 | 74058.38 |
Cipla | 789.50 | 0.38 | 63669.22 |
Aurobindo Pharma | 873.20 | 2.14 | 51160.79 |
Biocon | 395.40 | 1.38 | 47448.00 |
Lupin | 1022.55 | 0.40 | 46387.98 |
Cipla Ltd - SHAREHOLDING PATTERN
|
|
Cipla Ltd - Research Reports
Date | Broker | Action | Price | Report |
15/10/2020 | Prabhudas Lilladher | Reduce | 787 | ![]() |
13/10/2020 | Edelweiss Securities | Buy | 814 | ![]() |
03/04/2020 | Emkay Global | Buy | 414 | ![]() |
Cipla Ltd - RETURNS
Period | BSE | NSE | Sensex | NIFTY |
1 Week | -0.46% | -0.33% | 0.21% | 0.58% |
1 Month | -1.99% | -2.06% | 2.57% | 3.36% |
3 Month | 4.49% | 4.53% | 11.63% | 12.61% |
6 Month | 7.09% | 7.23% | 28.15% | 28.69% |
1 Year | 96.66% | 96.42% | 30.17% | 31.78% |
3 Year | 35.68% | 35.77% | 46.42% | 41.15% |
Cipla Ltd - STOCK STRENGTH
Today's Low/High | 782.05 | 807.70 | |
Week Low/High | 740.00 | 820.00 | |
Month Low/High | 740.00 | 879.00 | |
YEAR Low/High | 356.75 | 879.00 | |
All TIME Low/High | 0.61 | 879.00 |
Quick Links for Cipla:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices